HOME >> MEDICINE >> NEWS
Landmark survey reveals asthma in children remains significantly out of control in the United States

New York, NY (December 8, 2004) Findings from one of the nation's largest and most comprehensive surveys about children and asthma to date, Children and Asthma in America, reveal that more than half (54%) of all children with asthma had a severe asthma attack in the past year and more than one quarter (27%) had an asthma attack so bad they thought their life was in danger. The survey results released today underscore the severity of asthma in children in the U.S. and the significant impact the disease has on children and their families.

Presented on behalf of Asthma Action America, the survey findings suggest the U.S. is still falling far short of the national treatment goals established for asthma, and reveal the majority of children with asthma do not have it under control. This places children at potential risk for a variety of consequences including frequent symptoms, missed school, restrictions on activities, emotional distress, hospitalization and even life-threatening asthma attacks. Asthma is one of the most common chronic illnesses among children, with an estimated 5.8 million American children four to 18 years of age currently with the condition.

"These are disturbing findings, especially since asthma is a highly controllable disease," said William Sears M.D, nationally acclaimed author, pediatrician and associate clinical professor of pediatrics at the University of California Irvine School of Medicine. "We need to help parents recognize that proper asthma control means children are symptom-free all or most of the time. Parents should talk to their healthcare professional about prevention of asthma symptoms and long-term management so their child does not suffer needlessly."

Asthma Control in Children: Are We Missing The Mark?

In the survey, four out of five respondents reported that their or their child's asthma was well (43%) or completely controlled (35%), yet children missed the mark on nearly ev
'"/>

Contact: Kathryn Ritzinger
kathryn_ritzinger@nyc.cohnwolfe.com
212-798-9829
Cohn & Wolfe
8-Dec-2004


Page: 1 2 3 4 5

Related medicine news :

1. Landmark antidepressant analysis demonstrated significant efficacy of Effexor®/Effexor XR
2. Landmark study shows coenzyme Q10 slows progressive decline in Parkinsons disease
3. Landmark XENDOS study shows Xenical prevents or delays the development of type 2 diabetes
4. Landmark study demonstrates potential for nerve regeneration treatment of stroke
5. Landmark study results published in NEJM highlight breakthrough treatment for heart failure
6. Landmark study uncovers reasons behind recurring back injury
7. Landmark clinical trial at 22 medical centers finds implanted heart pumps lengthen and improve lives of terminally ill heart failure patients
8. Landmark dialysis study findings could greatly simplify treatment of kidney disease with peritoneal dialysis
9. Landmark school-based social influences smoking-prevention program found not to work
10. U.S., British scientific societies honor penicillin as International Chemical Landmark
11. CODE-2*: Landmark study on the costs of type 2 diabetes in Europe

Post Your Comments:
(Date:7/28/2014)... (PRWEB) July 28, 2014 Community Health ... primary medical, dental, and pharmacy services, has released an ... chronic disease management . Founded in 1983, the ... to those of the county that face barriers to ... To make an appointment at the CHC, click here: ...
(Date:7/28/2014)... South Carolina (PRWEB) July 28, 2014 ... enjoy their first bite of food best, with each ... Over-indulging, the researchers found, can actually serve to sabotage ... overindulge in foods they enjoy, not realizing the effect," ... "This is the argument for moderation, if we needed ...
(Date:7/28/2014)... Myers, Florida (PRWEB) July 28, 2014 ... management business process outsourcing (BPO) for Fortune 500 brands, ... 2,500 jobs across its locations in Wisconsin, California, Florida ... will be based at its Fort Myers campus, and ... available. , The hiring is to support several health-insurance ...
(Date:7/28/2014)... (PRWEB) July 28, 2014 Maternal and ... Allan Tucker Award, which will be presented at the ... on October 29th at the Westmoreland Club in Wilkes-Barre. ... County Commissioner and long-time employee of MFHS. She ... leader, political activist, health advocate, and champion for women, ...
(Date:7/28/2014)... 2014 Labors.at, Austria’s largest and ... Healthcare Relationship Cloud™ to fuel its growth initiatives. ... to 8,000 patients daily and performs up to ... up to doubling its volume within the next ... cutting-edge 10,000 square meter facility pushed our team ...
Breaking Medicine News(10 mins):Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 2Health News:Community Health Center of Snohomish Releases Article Focusing on Educating the Chronically Ill About Chronic Disease Management 3Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 2Health News:Large Portions Can Decrease Food Enjoyment, SlimPlate Weight Loss System Puts Focus On Portion Control 3Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 2Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 3Health News:Alta Resources To Fill Approximately 1,200 Positions In Fort Myers 4Health News:MFHS Seeking Nominations for Rose Allan Tucker Award 2Health News:Austrian Laboratory Leader, Labors.at, Fuels Growth with the hc1® Healthcare Relationship Cloud™ 2
(Date:7/28/2014)... 2014  ProteinSimple announced today that it has launched ... assay allows users to detect all proteins separated in ... users can analyze proteins without the need for an ... protein analysis as we know it today. First, the Simple ... no messy gels, no transfer tanks, no blots, no ...
(Date:7/28/2014)... und LONDON , July ... , Ziel der Zusammenarbeit sind Entwicklung und Kommerzialisierung ... Plasmaproben zur Steuerung von Therapien mit IRESSA bei ... Neuer Bluttest basiert auf QIAGENs von der ... Rotor-Gene Q, einer Automationsplattform der QIAsymphony-Produktfamilie, laufen  ...
(Date:7/28/2014)... and LONDON , July 28, ... aims to create and commercialize companion diagnostic using genomic ... IRESSA  for non-small cell lung cancer patients  ...   EGFR test and is planned to run on Rotor-Gene Q, member ... Project enabled by AstraZeneca master framework agreement adds to ...
Breaking Medicine Technology:ProteinSimple Says "Never Run a Gel Again!" 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 2QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 3QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 4QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 5QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 6QIAGEN und AstraZeneca entwickeln Begleittest auf Basis von Flüssigbiopsien zur erweiterten Bestimmung von EGFR-Mutationen bei Lungenkrebspatienten 7QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 2QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 3QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 4QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 5QIAGEN and AstraZeneca Collaborate to Develop Liquid Biopsy-Based Companion Diagnostic to Advance EGFR Mutation Profiling in Lung Cancer Patients 6
Cached News: